ARX:ASX
Aroa Biosurgery Ltd
AU$ 0,49
arrow_upward
+1,03%(+0,0050) 1D
5 nov, 16:10:29 GMT+11 · AUD
search
Alle symbolen
| Symbool | Prijs | Wijziging | Wijzigingspercentage |
|---|
insights_autoBelangrijkste inzichten voor ARX genereren…
Openen
AU$ 0,52
Hoog
AU$ 0,52
Laag
AU$ 0,49
Beursw.
167,76 mln.
Gem. vol.
282,16K
Volume
64,69K
Koers/winst-verhouding
47,43
52 wk hoog
AU$ 0,80
52 wk laag
AU$ 0,48
WPA
AU$ 0,01
Uitstaande aandelen
345,90 mln.
Aantal medewerkers
261
Openen
AU$ 0,52
Hoog
AU$ 0,52
Laag
AU$ 0,49
Beursw.
167,76 mln.
Gem. vol.
282,16K
Volume
64,69K
Koers/winst-verhouding
47,43
52 wk hoog
AU$ 0,80
52 wk laag
AU$ 0,48
WPA
AU$ 0,01
Uitstaande aandelen
345,90 mln.
Aantal medewerkers
261
Nieuwsartikelen
Van webbronnen en nieuwspartners
www.marketscreener.com
·
2 dagen geleden
Aroa Biosurgery : Mark Dunwoodie appointed as Chief Financial Officer
Profiel
Aroa Biosurgery Limited is a regenerative medicine company that develops, manufactures and distributes products for wound healing and soft tissue reconstruction. Aroa Biosurgery is headquartered in Auckland, New Zealand with a US office in San Diego, CA, and is listed on the Australian Securities Exchange.
The company, originally known as Mesynthes Limited, was founded in 2008 by Veterinarian Surgeon Dr Brian Ward. The company develops and commercializes products based on its proprietary ovine forestomach matrix technology platform with products in wound healing as well as plastics and reconstructive surgery and repair of hernia. Wikipedia
Over Aroa Biosurgery Ltd